Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1996 Nov;40(11):2555–2557. doi: 10.1128/aac.40.11.2555

Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation.

D M Lewinsohn 1, R A Bowden 1, D Mattson 1, S W Crawford 1
PMCID: PMC163574  PMID: 8913463

Abstract

Respiratory syncytial virus (RSV) pneumonia in marrow transplant recipients is associated with significant mortality. Ribavirin is a nucleoside analog with activity against RSV and in its aerosolized formulation is the only drug approved for treatment of RSV pneumonia in the United States. The clinical use of aerosolized ribavirin has been limited by caregivers' concerns about drug exposure and potential teratogenic effects. Since there is lack of proven efficacy and safety of the aerosolized ribavirin in this setting, we performed a phase I study of intravenous ribavirin treatment. Between November 1993 and May 1994, 10 patients with clinically significant RSV pneumonia at the Fred Hutchinson Cancer Research Center were enrolled. Only 2 of the 10 survived (20%; 95% CI, 3-56). Two of the 10 patients developed acute hemolysis that necessitated discontinuation of the medication. In conclusion, treatment of marrow transplant recipients with RSV pneumonia with intravenous ribavirin did not improve mortality compared with historical controls treated with the aerosolized drug.

Full Text

The Full Text of this article is available as a PDF (153.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry M., Russi M., Armstrong L., Geller D., Tesh R., Dembry L., Gonzalez J. P., Khan A. S., Peters C. J. Brief report: treatment of a laboratory-acquired Sabiá virus infection. N Engl J Med. 1995 Aug 3;333(5):294–296. doi: 10.1056/NEJM199508033330505. [DOI] [PubMed] [Google Scholar]
  2. Canonico P. G., Kastello M. D., Spears C. T., Brown J. R., Jackson E. A., Jenkins D. E. Effects of ribavirin on red blood cells. Toxicol Appl Pharmacol. 1984 Jun 30;74(2):155–162. doi: 10.1016/0041-008x(84)90138-8. [DOI] [PubMed] [Google Scholar]
  3. Englund J. A., Sullivan C. J., Jordan M. C., Dehner L. P., Vercellotti G. M., Balfour H. H., Jr Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med. 1988 Aug 1;109(3):203–208. doi: 10.7326/0003-4819-109-3-203. [DOI] [PubMed] [Google Scholar]
  4. Enria D. A., Maiztegui J. I. Antiviral treatment of Argentine hemorrhagic fever. Antiviral Res. 1994 Jan;23(1):23–31. doi: 10.1016/0166-3542(94)90030-2. [DOI] [PubMed] [Google Scholar]
  5. Hall C. B., McBride J. T., Walsh E. E., Bell D. M., Gala C. L., Hildreth S., Ten Eyck L. G., Hall W. J. Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study. N Engl J Med. 1983 Jun 16;308(24):1443–1447. doi: 10.1056/NEJM198306163082403. [DOI] [PubMed] [Google Scholar]
  6. Harrington R. D., Hooton T. M., Hackman R. C., Storch G. A., Osborne B., Gleaves C. A., Benson A., Meyers J. D. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis. 1992 Jun;165(6):987–993. doi: 10.1093/infdis/165.6.987. [DOI] [PubMed] [Google Scholar]
  7. Hertz M. I., Englund J. A., Snover D., Bitterman P. B., McGlave P. B. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine (Baltimore) 1989 Sep;68(5):269–281. doi: 10.1097/00005792-198909000-00002. [DOI] [PubMed] [Google Scholar]
  8. Hruska J. F., Bernstein J. M., Douglas R. G., Jr, Hall C. B. Effects of ribavirin on respiratory syncytial virus in vitro. Antimicrob Agents Chemother. 1980 May;17(5):770–775. doi: 10.1128/aac.17.5.770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Huggins J. W., Hsiang C. M., Cosgriff T. M., Guang M. Y., Smith J. I., Wu Z. O., LeDuc J. W., Zheng Z. M., Meegan J. M., Wang Q. N. Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991 Dec;164(6):1119–1127. doi: 10.1093/infdis/164.6.1119. [DOI] [PubMed] [Google Scholar]
  10. Kang J. O., Pai C. H. In situ enzyme immunoassay for antiviral susceptibility testing of respiratory syncytial virus. Am J Clin Pathol. 1989 Mar;91(3):323–326. doi: 10.1093/ajcp/91.3.323. [DOI] [PubMed] [Google Scholar]
  11. Kawana F., Shigeta S., De Clercq E. Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro. Antiviral Res. 1985;Suppl 1:83–88. doi: 10.1016/s0166-3542(85)80012-7. [DOI] [PubMed] [Google Scholar]
  12. Liles W. C., Cushing H., Holt S., Bryan C., Hackman R. C. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant. 1993 Oct;12(4):409–412. [PubMed] [Google Scholar]
  13. McCormick J. B., King I. J., Webb P. A., Scribner C. L., Craven R. B., Johnson K. M., Elliott L. H., Belmont-Williams R. Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986 Jan 2;314(1):20–26. doi: 10.1056/NEJM198601023140104. [DOI] [PubMed] [Google Scholar]
  14. Rodriguez W. J., Bui R. H., Connor J. D., Kim H. W., Brandt C. D., Parrott R. H., Burch B., Mace J. Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother. 1987 Jul;31(7):1143–1146. doi: 10.1128/aac.31.7.1143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Whimbey E., Champlin R. E., Couch R. B., Englund J. A., Goodrich J. M., Raad I., Przepiorka D., Lewis V. A., Mirza N., Yousuf H. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis. 1996 May;22(5):778–782. doi: 10.1093/clinids/22.5.778. [DOI] [PubMed] [Google Scholar]
  16. Whimbey E., Champlin R. E., Englund J. A., Mirza N. Q., Piedra P. A., Goodrich J. M., Przepiorka D., Luna M. A., Morice R. C., Neumann J. L. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant. 1995 Sep;16(3):393–399. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES